SWOG clinical trial number

SWOG-9455

A Phase II Study of 5-FU Infusion and Alpha Interferon for Treatment of Advanced or Recurrent Metastatic Adenocarcinoma of the Bladder

Closed

Phase

Accrual

8%

Abbreviated Title

Advanced Bladder

Activated

11/15/1996

Closed

12/01/1998

Research committees

Genitourinary Cancer

Other Clinical Trials

SWOG Clinical Trial Number

S2312

A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with metastatic castrate-resistant prostate cancer (mCRPC), Stratified by Aggressive Variant Signature

Research Committee(s)

Genitourinary Cancer

Activated

09/03/2024

Accrual

0%

Open

Phase

SWOG Clinical Trial Number

S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"

Research Committee(s)

Genitourinary Cancer

Activated

08/14/2023

Accrual

7%

Open

Phase

SWOG Clinical Trial Number

S2200

S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2

Research Committee(s)

Genitourinary Cancer

Activated

09/19/2022

Accrual

14%

Open

Phase